Cargando…
Assessing MicroRNA-375 Levels in Type 2 Diabetes Mellitus (T2DM) Patients and Their First-Degree Relatives with T2DM
PURPOSE: The pancreatic islet specific microRNA-375 (miR-375) is overexpressed in type 2 diabetes mellitus (T2DM) patients suppressing the glucose-induced insulin secretion. Thus, miR-375 may serve as a biomarker for the early prediction of T2DM among high-risk individuals. We conducted this clinica...
Autores principales: | Wu, Xu, Li, Yashan, Man, Baohua, Li, Dexuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018570/ https://www.ncbi.nlm.nih.gov/pubmed/33824598 http://dx.doi.org/10.2147/DMSO.S298735 |
Ejemplares similares
-
MicroRNAs as biomarkers for monitoring cardiovascular changes in Type II Diabetes Mellitus (T2DM) and exercise
por: Saini, Volga M, et al.
Publicado: (2022) -
I-14
Molecular pathomechanism of DM2/PROMM:
similarities and differences between DM1 and
DM2
por: Meola, G.
Publicado: (2011) -
Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
por: Kloc, Małgorzata, et al.
Publicado: (2020) -
T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients
por: Thummasorn, Savitree, et al.
Publicado: (2022) -
Comorbidity Analysis between Alzheimer’s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs
por: Karki, Reagon, et al.
Publicado: (2017)